Shuttle Pharmaceuticals Stock Market Value
| SHPH Stock | USD 0.37 0.06 13.95% |
| Symbol | Shuttle |
Shuttle Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Shuttle Pharmaceuticals. If investors know Shuttle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Shuttle Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Shuttle Pharmaceuticals is measured differently than its book value, which is the value of Shuttle that is recorded on the company's balance sheet. Investors also form their own opinion of Shuttle Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Shuttle Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Shuttle Pharmaceuticals' market value can be influenced by many factors that don't directly affect Shuttle Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Shuttle Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Shuttle Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shuttle Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Shuttle Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Shuttle Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Shuttle Pharmaceuticals.
| 12/15/2024 |
| 03/15/2025 |
If you would invest 0.00 in Shuttle Pharmaceuticals on December 15, 2024 and sell it all today you would earn a total of 0.00 from holding Shuttle Pharmaceuticals or generate 0.0% return on investment in Shuttle Pharmaceuticals over 90 days. Shuttle Pharmaceuticals is related to or competes with Lifecore Biomedical, Tilray, Organogenesis Holdings, Journey Medical, and Akanda Corp. Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery,... More
Shuttle Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Shuttle Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Shuttle Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 25.23 | |||
| Value At Risk | (8.82) | |||
| Potential Upside | 11.36 |
Shuttle Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Shuttle Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Shuttle Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Shuttle Pharmaceuticals historical prices to predict the future Shuttle Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (0.85) | |||
| Total Risk Alpha | (0.20) | |||
| Treynor Ratio | (1.49) |
Shuttle Pharmaceuticals Backtested Returns
Shuttle Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.14, which indicates the firm had a -0.14 % return per unit of risk over the last 3 months. Shuttle Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Shuttle Pharmaceuticals' Coefficient Of Variation of (629.00), risk adjusted performance of (0.13), and Variance of 32.42 to confirm the risk estimate we provide. The entity has a beta of 0.62, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Shuttle Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Shuttle Pharmaceuticals is expected to be smaller as well. At this point, Shuttle Pharmaceuticals has a negative expected return of -0.84%. Please make sure to validate Shuttle Pharmaceuticals' value at risk, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to decide if Shuttle Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.47 |
Modest reverse predictability
Shuttle Pharmaceuticals has modest reverse predictability. Overlapping area represents the amount of predictability between Shuttle Pharmaceuticals time series from 15th of December 2024 to 29th of January 2025 and 29th of January 2025 to 15th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Shuttle Pharmaceuticals price movement. The serial correlation of -0.47 indicates that about 47.0% of current Shuttle Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.47 | |
| Spearman Rank Test | -0.67 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Shuttle Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Shuttle Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Shuttle Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Shuttle Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Shuttle Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Shuttle Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Shuttle Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Shuttle Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Shuttle Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Shuttle Pharmaceuticals Lagged Returns
When evaluating Shuttle Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Shuttle Pharmaceuticals stock have on its future price. Shuttle Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Shuttle Pharmaceuticals autocorrelation shows the relationship between Shuttle Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Shuttle Pharmaceuticals.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Shuttle Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Shuttle Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Shuttle Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Shuttle Pharmaceuticals Stock:Check out Shuttle Pharmaceuticals Correlation, Shuttle Pharmaceuticals Volatility and Shuttle Pharmaceuticals Alpha and Beta module to complement your research on Shuttle Pharmaceuticals. For more detail on how to invest in Shuttle Stock please use our How to Invest in Shuttle Pharmaceuticals guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Shuttle Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.